TrialResults-center.org
Search
Menu
Home
Search
Recent trials
Browse pathology
Browse treatment
About us
acute heart failure
Description
NMA
NMA
Group by
Group by...
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in first
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in second
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in third
ultrafiltration
all type of patients
all type of patients
all type of patients
all type of patients
all type of patients
all type of patients
all type of patients
all type of patients
all type of patients
all type of patients
levosimendan
nesiritide
rolofylline
serelaxin
tolvaptan
tonapofylline
beta-blockers
endothelin receptor antagonist
human B-type natriuretic peptide
levosimendan
oral vasopressin antagonist
relaxine
selective adenosine-1 receptor antagonist
ultrafiltration
vs placebo or control
vs active treatment
All cause death
Cardiovascular death
hospitalisation for heart failure
hospitalisation for cardiovascular causes
Death from any cause or hospitalization for heart failure
CV death, MI hospitalization for HF
death or hospitalization
Cardiovascular death or hospital admission for CHF
heart failure death
30-day death
BNP under treatment
amelioration of Dyspnea at 24 h
Amelioration of Dyspnea at 6 h
mechanism
treatment
k
Demonstrated benefit and harm
×
Modal title
